Mary Caldorera-Moore

TL;DR: An overview of available nanoscale drug carriers is provided by exploring the wide variety of developed nanostructures and the most commonly used moieties for targeted delivery by examining tumor physiology and the specific barriers present within both the tumor microenvironment and systemic delivery.

TL;DR: The integration of responsive biomaterials into shape-specific nanocarriers is one of the most promising avenues towards the development of next generation, advanced drug delivery systems.

TL;DR: Recent advances in the field of nanotheranostics are explored and targeted theranostic nanocarriers offer an attractive improvement to disease treatment because of their ability to execute simultaneous functions at targeted diseased sites.

TL;DR: A high-throughput nanofabrication technique using synthetic and biological macromers (peptides) to produce highly monodisperse, enzymatically-triggered nanoparticles of precise sizes and shapes is reported, providing a potential means for disease-controlled delivery of biomolecules.

TL;DR: Improvements in micro- and nano-fabrication technologies have enhanced the ability to create better performing therapeutic systems for numerous pathophysiological applications, and MEMS- and NEMS-based tissue regeneration scaffolds, biosensors, and drug delivery devices provide new opportunities to mimic the natural intelligence and response of biological systems.